Crisil Ratings
Retail

Mall Operators’ Revenues To Surge 12–14% In FY26, Says Crisil

Crisil expects Indian mall operators to post 12–14 per cent revenue growth this fiscal, driven by new assets, higher occupancy and stronger retail demand.

Read More
Food

Poultry Revenue To Rise 4–6% This Fiscal: Crisil

Crisil expects India’s poultry sector revenue to grow 4–6 per cent this fiscal, driven by strong demand, though margins will tighten on weak broiler prices.

Read More
Companies National News

Indian Corporates See Slowest Revenue Growth In Q4, Led by Moderation In Consumer Demand

Corporates in India have likely logged a 4-6 per cent revenue growth in the January-March quarter, marking the slowest quarterly growth since recovery from the Covid-19 pandemic began in September 2021, as per an analysis of 350 companies (excluding financial services and oil and gas sectors) by Crisil Ratings. The moderation is, though, on a […]

Read More
Economy National News

Crisil Ratings Forecasts 6.8% GDP Growth For India In FY25

Crisil Ratings, an Indian rating agency, forecast a 6.8 per cent growth in India’s GDP for the upcoming fiscal year. Their India Outlook report predicts the country’s economy will benefit from domestic reforms and cyclical trends, potentially solidifying its position as the world’s third-largest economy by 2031. The report acknowledges a projected moderation from the […]

Read More
Companies News

Indian Cement Industry Plans 150-160 MT Capacity Expansion Over 4 Yrs

The cement industry, spurred by rising demand in infrastructure and housing, is set for a significant capacity expansion, aiming to add 150-160 million tonne (MT) from FY25 to FY28, according to a report by Crisil Ratings. Over the past five fiscal years, the industry has already augmented its capacity by 119 MT annually, reaching a […]

Read More
Health National News

Bulk Drugs Segment Of Indian Pharma Sector To See 6-8% Growth In FY24

The bulk drugs segment of the Indian pharmaceutical sector is expected to see revenue grow at 6 to 8 per cent this fiscal year, helped by higher sales volume stemming from a stable growth outlook, according to a Crisil Ratings report. The bulk drug segment posted 8-10 per cent revenue growth last fiscal, mainly because […]

Read More